Zdrowie i gospodarka · 25/01/2024
FDA Announces Voluntary Quality Management Maturity Program for CDER-Regulated Drug Manufacturers
The FDA is seeking a limited number of manufacturers of CDER-regulated drug products to participate in a voluntary program that evaluates quality management maturity using a prototype assessment protocol.